Product Liability Insurance for Medical Device Manufacturers: What Brokers Need to Know

Product liability risk for medical device manufacturers has changed significantly in recent years. For wholesale brokers, that shift is showing up in more complex placements, closer underwriting scrutiny, and greater expectations around how coverage is structured.

Today’s devices are more advanced, more connected, and more software-driven than ever before. Artificial intelligence (AI), cloud connectivity, remote monitoring, and software as a medical device (SaMD) are improving patient care while introducing new sources of liability.

At the same time, regulatory oversight is increasing. Approval processes may be more flexible, but expectations for how devices perform once they are in use, along with recalls and ongoing risk tracking, are higher. A defect, cybersecurity vulnerability, or failure to warn can now lead to rapid recalls, regulatory action, and costly litigation.

As a result, medical device product liability coverage must address more than traditional manufacturing defects. It needs to reflect how modern devices are designed, updated, and used in practice.

Understanding how these risks are evolving and what to look for in coverage is essential for brokers placing MedTech business.

How Regulatory Changes Are Reshaping Product Liability Risk

Regulatory expectations for medical device manufacturers have shifted toward greater accountability across the entire product lifecycle, from development through post-sale use. While these changes support innovation, they also increase exposure when issues arise.

Greater Focus on How Devices Perform After Launch

Regulators are placing increased emphasis on how devices perform once they reach the market.

Manufacturers are expected to monitor safety data, track adverse events, and respond quickly to emerging risks, especially for software-driven and AI-enabled devices.

Approval is no longer the finish line. If manufacturers fail to act on post-market data or update warnings, the risk of recalls, enforcement actions, and third-party claims increases.

For brokers, this means underwriters are looking more closely at how manufacturers monitor and respond to issues after launch, not just how the product is designed.

Modernized Quality System Expectations

Regulatory agencies have updated quality system requirements to better align with global standards. These updates reinforce the importance of documented risk management, supplier oversight, and corrective actions throughout the product lifecycle.

In product liability claims, gaps in quality systems or documentation can play a central role in allegations of design defects, manufacturing defects, or failure to warn.

In practice, this can influence underwriting appetite, pricing, and the level of detail underwriters require.

Cybersecurity Is Now a Product Liability Issue

As medical devices become more connected, regulators increasingly view cybersecurity as a patient safety concern rather than just an IT issue.

Manufacturers are expected to address cybersecurity risks through secure design, timely software updates, and ongoing vulnerability management. This aligns with evolving FDA medical device cybersecurity requirements and broader expectations around connected products.

Cyber incidents that disrupt device performance or compromise patient data can now contribute directly to product liability claims, even without a traditional mechanical defect.

For brokers, cybersecurity exposure is no longer separate from product liability. It is part of the same risk conversation.

Increased Transparency and Recall Scrutiny

Regulators have improved recall communication and transparency. While this helps protect patients, it can also accelerate the pace and scope of recalls.

This increases financial, operational, and reputational exposure for manufacturers.

Product liability insurance for medtech companies should be designed to respond not only to claims, but also to recall-related costs and crisis response needs.

For brokers, recall exposure is becoming a more central part of coverage discussions and program design.

Why Product Liability Coverage Must Evolve for Medical Device Manufacturers

As regulatory expectations shift, medical device manufacturers need insurance that reflects how their products actually function in today’s environment.

Coverage should respond to defense and indemnity needs while also addressing recall expenses, regulatory actions, and technology-driven risks such as AI medical device liability and software as a medical device insurance considerations.

Underwriters are increasingly focused on how manufacturers manage risk throughout the life of the device. Brokers who understand these expectations are better positioned to secure effective coverage and avoid gaps.

How Admiral is Helping Brokers Navigate a Changing MedTech Risk Landscape

Medical device innovation continues to advance, and with it, the complexity of product liability risk.

AI-enabled devices, connected technologies, increased regulatory scrutiny, and faster recall cycles are changing how risk is evaluated and how coverage needs to respond. These exposures extend well beyond traditional product defects.

Admiral Insurance Group has deep experience working with medical device manufacturers and a clear understanding of how emerging technologies, regulatory expectations, and real-world use affect product liability risk.

Our approach focuses on making sure coverage reflects how devices are designed, manufactured, distributed, and supported throughout their lifecycle.

As the MedTech industry evolves, brokers need an insurance partner that understands both innovation and accountability and can help ensure coverage keeps pace with changing risk profiles.

For wholesale brokers placing medical device risks, having the right carrier partner is critical. Contact us to become an appointed broker and access underwriting expertise focused on today’s MedTech risks.